CDCP1 and neoplasm: Taken together, high CDCP1 expression in PDAC defines a distinct molecular phenotype characterized by a combination of immunosuppressive TME, reduced stromal composition, enhanced genomic instability, and activation of multiple oncogenic signaling pathways, collectively shaping an aggressive tumor state associated with poor clinical outcome.